Frontotemporal Dementia Ftd Epidemiology Forecast

DelveInsight's 'Frontotemporal Dementia (FTD) - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Frontotemporal Dementia (FTD) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


Study Period: 2017-2030


Frontotemporal Dementia (FTD) Understanding

Frontotemporal degeneration (FTD) refers to a spectrum of clinical syndromes that demonstrate progressive degenerative changes in behavior, personality, language, cognitive skills and motor function. As a group, these disorders typically have brain atrophy in the frontal and/or temporal lobes. FTD is considered a young-onset dementia, occurring between the ages of 45 to 65 and is the most common dementia in those under 60 years of age. It displays clinical symptoms that can be mistaken for other dementias or psychiatric disorders.


Frontotemporal Dementia (FTD) Epidemiology Perspective by DelveInsight

The Frontotemporal Dementia (FTD) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every seven major countries. The epidemiology data for Frontotemporal Dementia are studied through all possible division to give a better understanding about the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Frontotemporal Dementia (FTD) Detailed Epidemiology Segmentation

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Diagnosed Prevalent cases of FTD, Prevalent cases of FTD by type, Subtype- specific cases of Primary Progressive Aphasia, Mutations associated with FTD) scenario of Frontotemporal Dementia (FTD) in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2017–2030.


The DelveInsight report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.


According to DelveInsight, the total number of prevalent cases of Frontotemporal Dementia (FTD) in 7 MM was found to be 76,499 in the year 2017.


Scope of the Report

  • The report covers detailed overview of Frontotemporal Dementia explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The report provides the insight about the historical and forecasted patient pool of Frontotemporal Dementia in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) and Japan
  • The Report assesses the disease risk and burden and highlights the unmet needs of the disease
  • The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report provides the segmentation of the disease epidemiology by Diagnosed Prevalent cases of FTD, Prevalent cases of FTD by type, Subtype- specific cases of Primary Progressive Aphasia, Mutations associated with FTD in 7MM


Report Highlights

  • 11-Year Forecast of Frontotemporal Dementia (FTD) epidemiology
  • 7MM Coverage
  • Total Cases of Frontotemporal Dementia (FTD)
  • Total Cases of Frontotemporal Dementia (FTD) according to segmentation
  • Diagnosed cases of Frontotemporal Dementia (FTD)


KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.


Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Frontotemporal Dementia (FTD)?
  • What are the key findings pertaining to the Frontotemporal Dementia (FTD) epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Frontotemporal Dementia (FTD) across the 7MM during the forecast period (2017-2030)?
  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Frontotemporal Dementia (FTD)?
  • What are the currently available treatments of Frontotemporal Dementia (FTD)?


Reasons to buy

  • The Frontotemporal Dementia (FTD) Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Frontotemporal Dementia (FTD) market
  • Quantify patient populations in the global Frontotemporal Dementia (FTD) market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Frontotemporal Dementia (FTD) therapeutics in each of the markets covered
  • Understand the magnitude of Frontotemporal Dementia (FTD) population by its epidemiology
  • The Frontotemporal Dementia (FTD) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights 

2. Executive Summary of Frontotemporal Dementia (FTD)

3. Frontotemporal Dementia (FTD): Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Frontotemporal Dementia (FTD) Epidemiology Scenario in the 7MM (2017- 2030)

5.4. United States Epidemiology

5.4.1. Frontotemporal Dementia (FTD) Epidemiology Scenario in the United States (2017- 2030)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. Frontotemporal Dementia (FTD) Epidemiology Scenario in Germany (2017- 2030)

5.5.2. France Epidemiology

5.5.2.1. Frontotemporal Dementia (FTD) Epidemiology Scenario in France (2017- 2030)

5.5.3. Italy Epidemiology

5.5.3.1. Frontotemporal Dementia (FTD) Epidemiology Scenario in Italy (2017- 2030)

5.5.4. Spain Epidemiology

5.5.4.1. Frontotemporal Dementia (FTD) Epidemiology Scenario in Spain (2017- 2030)

5.5.5. United Kingdom Epidemiology

5.5.5.1. Frontotemporal Dementia (FTD) Epidemiology Scenario in the United Kingdom (2017-2030)

5.6. Japan Epidemiology

5.6.1. Frontotemporal Dementia (FTD) Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Frontotemporal Dementia (FTD) Treatment and Management

6.2. Frontotemporal Dementia (FTD) Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

Table 1  Frontotemporal Dementia (FTD) Epidemiology in 7MM (2017-2030)

Table 2 Frontotemporal Dementia (FTD) Diagnosed and Treatable Cases in 7MM (2017-2030)

Table 3 Frontotemporal Dementia (FTD) Epidemiology in the United States (2017-2030)

Table 4 Frontotemporal Dementia (FTD) Diagnosed and Treatable Cases in the United States (2017-2030)

Table 5 Frontotemporal Dementia (FTD) Epidemiology in Germany (2017-2030)

Table 6 Frontotemporal Dementia (FTD) Diagnosed and Treatable Cases in Germany (2017-2030)

Table 7 Frontotemporal Dementia (FTD) Epidemiology in France (2017-2030)

Table 8 Frontotemporal Dementia (FTD) Diagnosed and Treatable Cases in France (2017-2030)

Table 9 Frontotemporal Dementia (FTD) Epidemiology in Italy (2017-2030)

Table 10 Frontotemporal Dementia (FTD) Diagnosed and Treatable Cases in Italy (2017-2030)

Table 11 Frontotemporal Dementia (FTD) Epidemiology in Spain (2017-2030)

Table 12 Frontotemporal Dementia (FTD) Diagnosed and Treatable Cases in Spain (2017-2030)

Table 13 Frontotemporal Dementia (FTD) Epidemiology in the United Kingdom (2017-2030)

Table 14 Frontotemporal Dementia (FTD) Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Table 15 Frontotemporal Dementia (FTD) Epidemiology in Japan (2017-2030)

Table 16 Frontotemporal Dementia (FTD) Diagnosed and Treatable Cases in Japan (2017-2030)

Figure 1 Frontotemporal Dementia (FTD) Epidemiology in 7MM (2017-2030)

Figure 2 Frontotemporal Dementia (FTD) Diagnosed and Treatable Cases in 7MM (2017-2030)

Figure 3 Frontotemporal Dementia (FTD) Epidemiology in the United States (2017-2030)

Figure 4 Frontotemporal Dementia (FTD) Diagnosed and Treatable Cases in the United States (2017-2030)

Figure 5 Frontotemporal Dementia (FTD) Epidemiology in Germany (2017-2030)

Figure 6 Frontotemporal Dementia (FTD) Diagnosed and Treatable Cases in Germany (2017-2030)

Figure 7 Frontotemporal Dementia (FTD) Epidemiology in France (2017-2030)

Figure 8 Frontotemporal Dementia (FTD) Diagnosed and Treatable Cases in France (2017-2030)

Figure 9 Frontotemporal Dementia (FTD) Epidemiology in Italy (2017-2030)

Figure 10 Frontotemporal Dementia (FTD) Diagnosed and Treatable Cases in Italy (2017-2030)

Figure 11 Frontotemporal Dementia (FTD) Epidemiology in Spain (2017-2030)

Figure 12 Frontotemporal Dementia (FTD) Diagnosed and Treatable Cases in Spain (2017-2030)

Figure 13 Frontotemporal Dementia (FTD) Epidemiology in the United Kingdom (2017-2030)

Figure 14 Frontotemporal Dementia (FTD) Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Figure 15 Frontotemporal Dementia (FTD) Epidemiology in Japan (2017-2030)

Figure 16 Frontotemporal Dementia (FTD) Diagnosed and Treatable Cases in Japan (2017-2030)

*The table of contents is not exhaustive; will be provided in the final report


  • Tags:
  • Frontotemporal Dementia (FTD) Epide...
  • Frontotemporal Dementia (FTD)
  • Frontotemporal Dementia (FTD) Pipe...
  • Frontotemporal Dementia (FTD) Comp...
  • Frontotemporal Dementia (FTD) prev...
  • Frontotemporal Dementia (FTD) inci...
  • Frontotemporal Dementia (FTD) pati...
  • Frontotemporal Dementia (FTD) trea...

Forward to Friend

Need A Quote